NCT05475925 2026-03-05A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic LymphomasDren BioPhase 1/2 Recruiting69 enrolled
NCT06035497 2025-05-14A Study to Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 (Golcadomide) in Participants With Relapsed or Refractory T-cell Lymphomas in Japan (GOLSEEK-3)Bristol-Myers SquibbPhase 1/2 Recruiting85 enrolled